Oncology

A recent study found that rural residence and certain tumor types, such as Hodgkin lymphoma, are among the leading causes of delayed cancer diagnosis in children. Delayed cancer diagnosis in children is a significant global health problem. Moreover, in its early stages, cancer symptoms are non-specific. This risk of delayed diagnosis is exceptionally high in...

A new study shows that higher exposure to pesticides among rural workers puts them at risk of Hodgkin lymphoma, autoimmune disorders, and other health issues caused by genotoxicity. Though the Green Revolution has helped increase food production globally, it has resulted in the indiscriminate use of pesticides in some nations, putting rural populations at risk....

In a first-of-its kind study, researchers evaluated the association between Human Development Index data and the prevalence of Hodgkin lymphoma.  Hodgkin lymphoma (HL) has a global annual incidence of about 83,000, causing more than 23,000 deaths globally, per the online database GOBOCAN 2020. Approximately 95% of all cases of HL are of classical Hodgkin lymphoma...

Staff Writer: Andre McGowan Cell-free DNA is reported to be an authentic diagnostic biomarker in breast cancer patients. A recent study supports this, noting significantly increased levels of cell-free DNA in a group of breast cancer patients. Increased levels of cell-free deoxyribose nucleic acid (cfDNA) in cancer cells are associated with a reduction in the...

With the development of more potent treatment options, the survival rate for Hodgkin lymphoma has increased over time. Treatment options for children with Hodgkin lymphoma (HL) have changed dramatically over the years, mainly as a result of developments in radiation therapy (RT) and chemotherapy (ChT). In the past, both children and adults received the same...

A recent literature review shows significant racial disparities, indicating that Black individuals are less likely to be screened despite having a higher lung cancer risk. The study also shows disparities in treatment and palliative care. Lung cancer is the second most common cancer and the leading cause of cancer deaths in the United States, accounting...

Immunotherapy is one of the newer treatment options for improving survivability in patients diagnosed with lung cancer. However, a recent study reports that lower-income and less educated people are less likely to receive these novel drugs, contributing to cancer treatment disparities. Lung cancer is among the leading causes of death in U.S. men and women....

Cetuximab maintenance therapy for wild-type metastatic colorectal cancer is associated with clinically significant overall and progression-free survival. However, cetuximab therapy following FOLFIRI plus cetuximab is not appropriate for patients with mutated mitogen-activated protein kinase, warranting refined treatment strategies. There continues to be a lack of consensus regarding the best option among de-escalation modalities for managing...

A recent study found that elimination of race and ethnicity as risk predictors for colorectal recurrence is associated with worsened fairness of the risk prediction model, resulting in inappropriate care for ethnic and racial minorities in the population. The inclusion of racial and ethnic parameters in the risk prediction models is often inadequate, reflecting the...